AstraZeneca PLC (AZN) vs Elevance Health Inc. (ELV)
A side-by-side comparison of AstraZeneca PLC and Elevance Health Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
AZN
AstraZeneca PLC
$160.17HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
ELV
Elevance Health Inc.
$418.72HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — AZN vs ELV
growth of $100 · dividends reinvested · last 10yAZN +228.1% (+12.6%/yr)ELV +284.4% (+14.4%/yr)ELV compounded faster over this window
AZN ELV
AZN vs ELV: by the numbers
- •AZN is the larger company ($248.40B vs $90.81B market cap).
- •ELV trades at the lower trailing earnings multiple (18.61 vs 24.05 P/E), one valuation lens rather than an overall verdict.
- •AZN converts more revenue to profit (17.02% vs 2.47% net margin).
- •AZN grew revenue faster over the past five years (15.76% vs 9.25% CAGR).
- •AZN pays the higher dividend yield (2.02% vs 1.65%).
Metrics side by side
Valuation
| Metric | AZN | ELV |
|---|---|---|
| P/E ratio | 24.05 | 18.61 |
| Forward P/E | 15.64 | 15.42 |
| P/S ratio | 4.05 | 0.45 |
| P/B ratio | 4.94 | 2.02 |
| EV / EBITDA | 13.56 | 13.82 |
| FCF yield | 3.52% | 6.93% |
Profitability
| Metric | AZN | ELV |
|---|---|---|
| Gross margin | 81.88% | 25.56% |
| Operating margin | 22.77% | 3.51% |
| Net margin | 17.02% | 2.47% |
| ROE | 20.79% | 11.06% |
| ROIC | 12.83% | 6.34% |
Dividends
| Metric | AZN | ELV |
|---|---|---|
| Dividend yield | 2.02% | 1.65% |
| Payout ratio | 48.50% | 30.49% |
Growth (annualized)
| Metric | AZN | ELV |
|---|---|---|
| Revenue CAGR (5Y) | 15.76% | 9.25% |
| EPS CAGR (5Y) | 22.02% | 6.67% |
| FCF CAGR (5Y) | 14.53% | -19.97% |
| Total return CAGR (5Y) | 9.46% | 4.62% |
Frequently asked
- Which has the lower trailing P/E, AZN or ELV?
- ELV has the lower trailing P/E: AZN trades at 24.05 and ELV at 18.61. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, AZN or ELV?
- Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus ELV at 9.25%.
- Does AZN or ELV pay a bigger dividend?
- AZN yields 2.02% and ELV yields 1.65% based on trailing dividends and the latest price.
- Is AZN or ELV more profitable?
- AZN runs the higher net margin — AZN at 17.02% versus ELV at 2.47%.
- How have AZN and ELV total returns compared?
- Over the past 10 years, AZN delivered 12.85% and ELV delivered 14.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioElevance Health P/E ratioAstraZeneca dividend yieldElevance Health dividend yieldAstraZeneca ROEElevance Health ROEAstraZeneca operating marginElevance Health operating marginAstraZeneca revenue growthElevance Health revenue growthAstraZeneca free cash flowElevance Health free cash flow
AstraZeneca & Elevance Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.